• 6816 Citations
  • 41 h-Index
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Teh is a professor and vice chair of the Department of Radiation Oncology at Houston Methodist Hospital and Weill Medical School of Cornell. Dr. Teh has contributed significantly to the field of radiation oncology – encompassing radiotherapy technology, radiation physics, molecular radiobiology and the translation of advances in these areas to clinical use. He has been instrumental in pioneering new technology in radiation oncology including APBI (accelerated partial breast irradiation), IMRT (intensity-modulated radiation therapy), IGRT (image-guided radiation therapy), SBRT (stereotactic body radiation therapy), SRS (stereotactic radiosurgery), brachytherapy as well as combined radiotherapy and gene therapy. Dr. Teh treated the first breast cancer patient in Houston with multi-lumen catheter (Contura) high dose rate brachytherapy for partial breast irradiation. This is a short course of five days irradiation, as compared to the conventional six weeks irradiation for breast cancer. Partial breast irradiation is a novel approach to spare more normal tissues.

Dr. Teh earned his medical degree from the University of Queensland in Queensland, Australia. He completed his Radiation Oncology residency, training and fellowship in IMRT at the Baylor College of Medicine in Houston, Texas. Dr. Teh is active in ASTRO (American Society of Therapeutic Radiology and Oncology), RSNA (Radiological Society of North America and ARS (American Radium Society). He is the principal investigator for RTOG (Radiation Therapy Oncology Group) at Houston Methodist Hospital. Dr. Teh has published more than 100 peer-reviewed articles on topics such as IMRT for breast cancer, editorials, 15 book chapters and a textbook on PET-CT in radiotherapy. He plays an important role in breast cancer patient care, clinical research and the education of residents and students.

Research interests

Dr. Teh’s research focuses on the treatment of genito-urinary malignancies and unlocking the myth of radio-resistance in cancers especially renal cell carcinoma. Other research interests include Intensity modulated radiation therapy (IMRT) for prostate cancer, head and neck cancer, central nervous system tumor, pediatric cancer and breast cancer, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), stereotactic radiation therapy (SRT) and image-guided radiation therapy (IGRT), brachytherapy for prostate cancer, breast cancer and endobronchial tumors, SRS and SBRT for primary and metastatic renal cell carcinoma as well as hepatocellular carcinoma, the role of combined radiotherapy and gene therapy for cancers including prostate cancer, renal cell carcinoma, bladder cancer, pancreatic cancer, glioblastoma multiforme, cervical cancer and head and neck cancer, combining targeted therapy (AKT-inhibitor, mTOR inhibitor, tyrosine kinase inhibitor) with radiotherapy for cancer treatment, and combining oncolytic virus with radiotherapy in overcoming radio-resistant tumors in oncology.

Education/Academic qualification

Radiation Oncology, Clinical Fellowship, Baylor College of Medicine

Jul 1 1998Jun 30 1999

Award Date: Jun 30 1999

Radiation Oncology, Residency, Baylor College of Medicine

Jul 1 1994Jun 30 1998

Award Date: Jun 30 1998

MD, University of Queensland

… → Dec 31 1990

Award Date: Dec 31 1990

Free-text keywords

  • Cancer stem cells
  • Radio-resistance
  • Prostate Movement study
  • Post-prostatectomy IMRT
  • Gene expression profiling in cancer
  • Proteomics in oncology

Research Area Keywords

  • Cancer
  • Imaging & Radiology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Clinical presentation, national practice patterns, and outcomes of breast adenomyoepithelioma

Haque, W. M., Verma, V., Suzanne Klimberg, V., Nangia, J., Schwartz, M., Butler, E. B. & Teh, B. S., Apr 1 2020, In : Breast Journal. 26, 4, p. 653-660 8 p.

Research output: Contribution to journalArticle

  • Comparison of outcomes between metaplastic and triple-negative breast cancer patients

    Polamraju, P., Haque, W., Cao, K., Verma, V., Schwartz, M., Klimberg, V. S., Hatch, S., Niravath, P., Butler, E. B. & Teh, B. S., Feb 2020, In : Breast. 49, p. 8-16 9 p.

    Research output: Contribution to journalArticle

  • Controversies in the Management of Solid Tumor Bone Metastases

    Farach, A. M., Butler, E. B. & Teh, B. S., 2020, Medical Radiology. Springer, p. 241-253 13 p. (Medical Radiology).

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma

    Agrusa, J. E., Kothari, V. D., Brown, A. L., Masand, P. M., Lewis, G. D., Teh, B. S., Paulino, A. C., Silva-Carmona, M. D., Melicoff, E., Allen, C. E. & Gramatges, M. M., Jun 10 2020, In : Leukemia and Lymphoma. p. 1-9 9 p.

    Research output: Contribution to journalArticle